exercised

Taiho Pharmaceutical Exercises Option for an Exclusive License to Casdatifan in Japan and Certain Territories in Asia

TOKYO & HAYWARD, Calif.--(BUSINESS WIRE)--Taiho Pharmaceutical Co., Ltd. (“Taiho”) and Arcus Biosciences, Inc. (NYSE:RCUS, “Arcus”) announced that Taiho exercised its…

3 days ago

Enovix Announces Completion of Warrant Dividend Program

September 05, 2025 18:08 ET  | Source: Enovix Corporation Warrants Expired and Ceased Trading on Friday, August 29, 2025 Approximately…

2 months ago

Diginex Announces Execution of Warrants Agreement, Bonus Share Issuance and Cancelation of EGM

July 25, 2025 20:00 ET  | Source: Diginex Limited LONDON, July 25, 2025 (GLOBE NEWSWIRE) -- Diginex Limited (“Diginex” or…

3 months ago

Xilio Therapeutics Announces Closing of $50.0 Million Public Offering

June 05, 2025 18:38 ET  | Source: Xilio Therapeutics, Inc. Total gross proceeds of up to $150.0 million before the…

5 months ago